Surgery (RMH) - Theses
Permanent URI for this collection
Search Results
1 - 1 of 1
-
ItemThe U12-dependent spliceosome is essential for regulating gene expression during zebrafish development( 2010)Removal of introns from pre-mRNA is an essential step in generating mature mRNA. The majority of introns are removed by the major, or U2-type, spliceosome, while the minor, or U12-type, spliceosome catalyses the removal of a small set of introns with characteristic features that are highly conserved in metazoans and plants. A novel zebrafish mutant, caliban (cal), with specific U12-type splicing defects, was used to study the biochemistry of the U12-type spliceosome and the role of U12-type introns in the regulation of gene expression. Greater than 99% of vertebrate introns are U2-type introns. However, a second class of U12-type introns exists that is defined by highly conserved consensus splice sites. U12-type introns represent about 0.5% of all introns in vertebrate genomes and usually occur alone alongside U2-type introns in pre-mRNA. U12-type introns are removed by a separate spliceosome that shares many components with the U2-type spliceosome, but contains several unique small nuclear RNAs (snRNAs) and spliceosomal proteins. Several lines of evidence suggest a function for U12-type splicing in the regulation of gene expression. These include the high evolutionary conservation of U12-type introns, their enrichment in certain functional gene groups and the demonstration that their excision can be rate-limiting in the generation of mature mRNAs. Despite these observations, little is known about the role and possible regulatory function of U12-type splicing in vivo. cal is a zebrafish development mutant with abnormalities in the intestinal epithelium, which is poorly polarised and unfolded compared to wildtype (wt). Mutant embryos also show a reduction in size of the liver and the pancreas and display a morphologically abnormal lens in the context of a smaller eye. The genetic lesion in cal was mapped to rnpc3, encoding the zebrafish orthologue of the human U11/U12 snRNP 65KDa protein, a specific component of the U12-type spliceosome. It was shown that cal embryos specifically retain U12-type introns compared to wildtype. Biochemical analyses of U12-type spliceosomal small nuclear ribonucleoproteins (snRNPs) demonstrate abnormal formation of the U11/U12 di-snRNP, which represents the first step in U12-type spliceosome assembly. However, it was also demonstrated that larger spliceosomal particles form and accumulate in cal embryos in the absence of Rnpc3/65K, suggesting a potential novel role for Rnpc3/65K in U12-type spliceosome disassembly and recycling. Whole transcriptome analysis of cal and wt embryos by microarrays and RNA sequencing demonstrated retention of U12-type introns on a global scale as well as a set of about 700 differentially expressed genes between cal and wt at two different developmental time points. Further analysis of gene expression data has led to the emergence of a model in which cal embryos are sustained through the first 48-72hpf by maternally deposited rnpc3 mRNA and Rnpc3/65K protein. After this time, defective U12-type splicing induces a cell cycle arrest in the endoderm-derived tissues of the liver, pancreas and intestine, which are highly proliferative between 72 and 108hpf. These results are leading to further studies with a focus on the role of U12-type splicing in human cancer. It was found that several prominent human tumour suppressor genes such as PTEN, LKB1 and PROX1, contain U12-type introns, and we propose a model by which an intermediate reduction of U12-type splicing efficiency can be tumourigenic by reducing the activity of particular tumour suppressor genes in a dose-dependent fashion. To test this hypothesis, conditional Rnpc3 knockout mouse models are currently being generated on a range of different colorectal cancer-susceptible backgrounds.